| Net Cash Provided by (Used in) Operating Activities |
$2,471,000 |
USD |
-7.9% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$2,735,000 |
USD |
9.5% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$206,000 |
USD |
-84% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
475,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
73,457,857 |
shares |
2% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$58,000 |
USD |
-38% |
Q3 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$40,000 |
USD |
-29% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$12,651,817 |
USD |
40% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$12,651,817 |
USD |
40% |
Q2 2025 |
FY 2025 |
| Depreciation |
$1,660 |
USD |
0% |
Q2 2025 |
FY 2025 |
| Property, Plant and Equipment, Gross |
$4,980 |
USD |
0% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$7,633,025 |
USD |
38% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
25,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Operating Lease, Payments |
$300 |
USD |
|
Q2 2025 |
FY 2025 |
| Additional Paid in Capital |
$31,332,000 |
USD |
3.5% |
Q3 2025 |
Q1 2026 |
| Interest Expense |
$801,628 |
USD |
|
Q1 2024 |
Q3 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
FY 2025 |